Dennis is Founder and Senior Advisor at Aisling Capital LLC. During his tenure, Dennis has been directly involved with over two hundred completed transactions and supervised over $15 billion of financing and advisory assignments in the pharmaceutical, biotechnology and medical products industries.
Dennis is a frequent commentator on the industry and has been honoured in various publications as a top contributor to the Life Sciences industry. He sits on numerous private and public healthcare company boards, such as Real Endpoints and Summus Global. He is actively involved with many of the industry’s professional organizations, such as BIO, the Life Sciences Foundation, the NYC Investment Fund and NYU’s office of Therapeutics Alliance. He is a member of the University of Delaware Investment Committee and Harvard Kennedy School – M-R CBG Advisory Council. He is Executive Chairman of Poliwogg Holdings, a company devising new financed products for the healthcare industry.